References
Every source cited on this site, in one place.
Guidelines
- Goueli R, Badlani GH, Welliver C, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline (2026), Parts I–III (evaluation; medical management; procedural/surgical management). J Urol. 2026. doi:10.1097/JU.0000000000005097, …5098, …5099. View source (opens in a new tab)
- Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline parts I and II. J Urol. 2021;206(4):806-826 (amended 2023; replaced by the 2026 edition). View source (opens in a new tab)
- European Association of Urology. EAU Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms (LUTS). 2026 edition. Arnhem: EAU Guidelines Office. View source (opens in a new tab)
- Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024. View source (opens in a new tab)
- Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA/SUO guideline parts I and II. J Urol. 2023;210(1):45-63. View source (opens in a new tab)
- U.S. Preventive Services Task Force. Prostate Cancer: Screening. Final recommendation statement, May 8, 2018 (update in progress). View source (opens in a new tab)
Clinical trials and research
- McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia (MTOPS). N Engl J Med. 2003;349(25):2387-2398. View source (opens in a new tab)
- Roehrborn CG, Barkin J, Gange SN, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24(3):8802-8813 (5-year results summarized by UroToday). View source (opens in a new tab)
- McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021;206(3):715-724. View source (opens in a new tab)
- Gilling PJ, Barber N, Bidair M, et al. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol. 2022;29(1):10960-10968. View source (opens in a new tab)
- Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148(5):1549-1557 (questionnaire items as catalogued by LOINC panel 80883-2). View source (opens in a new tab)
Patient resources
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Enlarged Prostate (Benign Prostatic Hyperplasia). U.S. National Institutes of Health. View source (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Urinary Retention. U.S. National Institutes of Health. View source (opens in a new tab)
- MedlinePlus Medical Encyclopedia. Urinating more at night. U.S. National Library of Medicine. View source (opens in a new tab)
- Urology Care Foundation. Benign Prostatic Hyperplasia (BPH). American Urological Association patient education. View source (opens in a new tab)
- National Cancer Institute. Prostate-Specific Antigen (PSA) Test. View source (opens in a new tab)
- National Cancer Institute. Kidney (Renal Cell) Cancer – Patient Version. View source (opens in a new tab)
- National Cancer Institute. What Is Bladder Cancer? View source (opens in a new tab)
About Dr. Saji
- Swedish Health Services. Physician profile: Akhil A. Saji, MD, Urology (education, areas of focus, location). View source (opens in a new tab)
- Doximity. Public profile: Akhil Saji, MD (education, training, licenses, publications). View source (opens in a new tab)
- Swedish Health Team. Enlarged prostate? Aquablation therapy offers relief. Swedish blog (quotes Dr. Saji). View source (opens in a new tab)
- GU Oncology Now. Author page: Akhil Abraham Saji, MD, urologist at Swedish Health Services. View source (opens in a new tab)